6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-10-05
DOI
10.1038/s41598-017-12788-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis
- (2017) Fabienne Le Cann et al. FEBS Journal
- Discovery of a Highly Potent, Selective, and Metabolically Stable Inhibitor of Receptor-Interacting Protein 1 (RIP1) for the Treatment of Systemic Inflammatory Response Syndrome
- (2017) Yan Ren et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
- (2017) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- An outline of necrosome triggers
- (2016) Tom Vanden Berghe et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Generation of small molecules to interfere with regulated necrosis
- (2016) Alexei Degterev et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors
- (2016) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Natural Products as Sources of New Drugs from 1981 to 2014
- (2016) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis
- (2016) Boris Strilic et al. NATURE
- Regulated necrosis: disease relevance and therapeutic opportunities
- (2016) Marcus Conrad et al. NATURE REVIEWS DRUG DISCOVERY
- A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
- (2015) A Fauster et al. Cell Death & Disease
- Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1
- (2015) Malek Najjar et al. Cell Reports
- Regulated necrosis: the expanding network of non-apoptotic cell death pathways
- (2014) Tom Vanden Berghe et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Necroptosis, in vivo detection in experimental disease models
- (2014) Sandrine Jouan-Lanhouet et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Structural Basis of RIP1 Inhibition by Necrostatins
- (2013) Tian Xie et al. STRUCTURE
- Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis
- (2013) Philip A. Harris et al. ACS Medicinal Chemistry Letters
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now